Trending Now
Jeffrey Epstein case reopens focus on Ghislaine Maxwell as deputy AG...
Musk may not be done with US politics: report
Trump calls for Obama to be criminally investigated, says he was...
SCOOP: Dem fundraising giant ActBlue hit with subpoena by top House...
Dems seek retaliation over GOP cuts as Thune calls for ‘cooperation’...
Chinese import shifts, infrastructure boom reshape global metals markets
Japan’s market is rallying, but its economy says it may be...
China’s heatwave fuels power crisis and health warnings
Obama denies Trump’s ‘bizarre allegations’ that he was Russiagate ‘ringleader’ in...
Huckabee hits back at Western countries that ‘side’ with terror group...
Jeffrey Epstein case reopens focus on Ghislaine Maxwell as deputy AG...
Musk may not be done with US politics: report
Trump calls for Obama to be criminally investigated, says he was...
SCOOP: Dem fundraising giant ActBlue hit with subpoena by top House...
Dems seek retaliation over GOP cuts as Thune calls for ‘cooperation’...
Chinese import shifts, infrastructure boom reshape global metals markets
Japan’s market is rallying, but its economy says it may be...
China’s heatwave fuels power crisis and health warnings
Obama denies Trump’s ‘bizarre allegations’ that he was Russiagate ‘ringleader’ in...
Huckabee hits back at Western countries that ‘side’ with terror group...
Insider Dealing News
  • Stock
  • Investing
  • Politics
  • World News
  • Editor’s Pick
World News

HHS slams ‘under-tested’ mRNA technology as Trump cuts Moderna’s vaccine funding

by May 29, 2025
written by May 29, 2025

President Donald Trump’s Department of Health and Human Services (HHS) is terminating awards totaling more than $750 million dollars that were provided to pharmaceutical manufacturer Moderna to help facilitate its production of mRNA-based bird flu vaccines. 

During President Joe Biden’s final week in office, his administration awarded $590 million to Moderna to help speed up its production of mRNA-based vaccines. The $590 million award followed a separate $176 million award Biden gave to Moderna earlier last year for mRNA vaccine technology.

Messenger RNA vaccines are a newer type of vaccine technology, which was utilized by companies like Moderna and Pfizer to develop their COVID-19 vaccines. The vaccine technology was at the center of a lot of criticism amid the coronavirus pandemic for potentially being associated with adverse side effects in some people who took them, such as myocarditis.

Trump administration officials previously hinted at the potential that this funding could be terminated, citing a lack of oversight during the Biden administration pertaining to vaccine production. 

‘After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,’ HHS Communications Director Andrew Nixon said. ‘This is not simply about efficacy — it’s about safety, integrity, and trust. The reality is that mRNA technology remains under-tested, and we are not going to spend taxpayer dollars repeating the mistakes of the last administration, which concealed legitimate safety concerns from the public.’

The announcement reflects a larger shift in federal vaccine priorities, after HHS Secretary Robert F. Kennedy Jr. announced earlier this week that COVID-19 vaccines would be removed from the federal government’s list of recommended vaccines for children and pregnant women. 

Meanwhile, a report from Senate Republicans released earlier this month suggested the Biden administration withheld critical safety data and downplayed known risks tied to the mRNA COVID-19 vaccine. In particular, the Senate report focuses on HHS’ awareness of, and response to, cases of myocarditis — a type of heart inflammation — following COVID-19 vaccination.

‘Rather than provide the public and health care providers with immediate and transparent information regarding the risk of myocarditis following mRNA COVID-19 vaccination, the Biden administration waited until late June 2021 to announce changes to the labels for the Moderna and Pfizer COVID-19 vaccines based on the ‘suggested increased risks’ of myocarditis and pericarditis,’ the Senate report states. ‘Even though CDC and FDA officials were well aware of the risk of myocarditis following COVID-19 vaccination, the Biden administration opted to withhold issuing a formal warning to the public for months about the safety concerns, jeopardizing the health of young Americans.’

In response to the Trump administration’s funding termination, Moderna put out a press release acknowledging the move, but also touting the ‘safety profile’ observed amid its work on a new mRNA bird flu vaccine.

‘While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program,’ said Stéphane Bancel, Chief Executive Officer of Moderna. ‘These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats.’

Fox News Digital’s Brooke Singman contributed to this report.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
State Department says it will ‘aggressively’ revoke visas for Chinese students
next post
Musk officially steps down from DOGE after wrapping work streamlining government

Related Posts

Dems seek retaliation over GOP cuts as Thune...

July 22, 2025

GOP lawmakers advocate for US condemnation of persecution...

July 22, 2025

‘Not going away’: Inside the Epstein drama that’s...

July 22, 2025

China denies wrongdoing in preventing dozens of Americans...

July 22, 2025

Salvadoran president responds to Hunter Biden’s invasion threat:...

July 22, 2025

Obama denies Trump’s ‘bizarre allegations’ that he was...

July 22, 2025

Huckabee hits back at Western countries that ‘side’...

July 22, 2025

Jeffrey Epstein case reopens focus on Ghislaine Maxwell...

July 22, 2025

Trump calls for Obama to be criminally investigated,...

July 22, 2025

SCOOP: Dem fundraising giant ActBlue hit with subpoena...

July 22, 2025

Dems seek retaliation over GOP cuts as Thune...

July 22, 2025

GOP lawmakers advocate for US condemnation of persecution...

July 22, 2025

‘Not going away’: Inside the Epstein drama that’s...

July 22, 2025

China denies wrongdoing in preventing dozens of Americans...

July 22, 2025

Salvadoran president responds to Hunter Biden’s invasion threat:...

July 22, 2025

Obama denies Trump’s ‘bizarre allegations’ that he was...

July 22, 2025

Huckabee hits back at Western countries that ‘side’...

July 22, 2025

Jeffrey Epstein case reopens focus on Ghislaine Maxwell...

July 22, 2025

Trump calls for Obama to be criminally investigated,...

July 22, 2025

SCOOP: Dem fundraising giant ActBlue hit with subpoena...

July 22, 2025







    Fill Out & Get More Relevant News





    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 InsiderDealingNews.com All Rights Reserved.

    Insider Dealing News
    • Stock
    • Investing
    • Politics
    • World News
    • Editor’s Pick